Sildenafil Citrate Market Size & Share, by Use (Medical and Non- Medical); Distribution Channel (Online and Offline); End User (Adults - Male, Medical Researchers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 2582
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Sildenafil Citrate Market size was valued at USD 1.58 billion in 2023 and is expected to reach USD 3.13 billion by 2036, expanding at around 5.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of sildenafil citrate is assessed at USD 1.65 billion.

The increase in erectile dysfunction cases on account of the rising cases related to heart diseases, diabetes, obesity, blood pressure, tobacco and alcohol consumption, depression, stress, food habits along with an ageing population are estimated to contribute to the market growth. Based on its use, the market is bifurcated into medical and non-medical usage, out of which, the largest share in the market is estimated to be held by medical segment in order to treat erectile dysfunction in men. This can be attributed to its low cost in the market and the requirement of a prescription by medical professionals. The market is further segmented by distributed channel into online and offline distribution channels. Among these segments, the offline segment is anticipated to continue holding the leading share in the market since it was the highest revenue generating segment in 2019 owing to the rising availability of the product. Additionally, the high product awareness is driving also contributed to the growth of the segment. 


Get more information on this report: Request Free Sample PDF

Sildenafil Citrate Sector: Growth Drivers and Challenges

Growth Drivers

  • Prevalence of Erectile Dysfunction: It is estimated that ageing in men increases the risk of erectile dysfunction in them. However it is stated that ED can occur at any age, but most common in older men. ED can be also be caused by heart-related diseases, diabetes, obesity, tobacco and alcohol consumption. According to the WHO, the proportion of world’s population over 60 years is estimated to nearly double from 12% to 22% between 2015 and 2020. Further, it was reported by IHME, that in 2017, 4.7 million deaths globally were caused by obesity and majority of the cases were reported in urban areas of the world where reduced activity and poor diets are attributed to accelerate the rise of it. Ageing population, prevalence of cardiovascular diseases, obesity and high consumption of alcohol and tobacco are factors contributing to increase in the number of ED cases and thus expected to positively impact the sildenafil citrate market.
  • Awareness towards ED by Governments and NGOs: Adult males shy away from the topic of ED in public discussions. Understanding and acceptance about ED and its prevalence among adult males through awareness programs by governments and NGOs is expected to drive the sildenafil citrate market forward.

Challenges

  • Availability of Erectile Dysfunction Alternatives: The availability of alternatives such as Tadalafil (Cialis), Vardenafil (Levitra) and Vardenafil (Staxyn) is expected to negatively impact the sales of sildenafil citrate medication and thus hamper the sildenafil citrate market growth in the coming years.

Sildenafil Citrate Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

5.4%

Base Year Market Size (2023)

USD 1.58 billion

Forecast Year Market Size (2036)

USD 3.13 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Sildenafil Citrate Segmentation

Our in-depth analysis of the global sildenafil citrate market includes the following segments

By Use

  • Medical
  • Non- Medical

By Distribution Channel

  • Online
  • Offline

By End User

  • Adults – Male
  • Medical Researchers
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Sildenafil Citrate Industry - Regional Synopsis

On the basis of regional analysis, the sildenafil citrate market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America industry is predicted to hold largest revenue share by 2036, propelled by higher number of ED cases in the region. The market in Asia Pacific region is predicted to grow at the highest rate during the forecast period as a result of ageing population in countries such as India, China, Japan and increase in awareness towards erectile dysfunction and related disorders.

Get more information on this report: Request Free Sample PDF

Companies Dominating the Sildenafil Citrate Landscape

    • Pfizer Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bayer AG
    • Apricus Biosciences, Inc.
    • Cristália
    • Aglowmed Pharmaceuticals Ltd.
    • Mylan N.V.
    • VIVUS Inc.
    • Eli Lilly and Company
    • Teva Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.

Author Credits:  Radhika Pawar


  • Report ID: 2582
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of sildenafil citrate is assessed at USD 1.65 billion.

Sildenafil Citrate Market size was valued at USD 1.58 billion in 2023 and is expected to reach USD 3.13 billion by 2036, expanding at around 5.4% CAGR during the forecast period i.e., between 2024-2036.

North America industry is predicted to hold largest revenue share by 2036, propelled by higher number of ED cases in the region.

The major players in the market are Pfizer Inc., Bayer AG, Apricus Biosciences, Inc., Cristália, Aglowmed Pharmaceuticals Ltd., Mylan N.V., VIVUS Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., and others.
Sildenafil Citrate Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample